The effect of budesonide (Rhinocort ) in the treatment of small and medium-sized nasal polyps
- 1 December 1993
- journal article
- clinical trial
- Published by Wiley in Clinical Otolaryngology
- Vol. 18 (6) , 524-527
- https://doi.org/10.1111/j.1365-2273.1993.tb00628.x
Abstract
The objectives of this study were to determine if the size of nasal polyps could be assessed in a reproducible way and to study the effect of budesonide in patients suffering from eosinophilic nasal polyposis with small and medium sized polyps. Ninety-one patients entered the study. Budesonide 200 micrograms b.i.d. (aerosol or aqua) and placebo (aerosol or aqua) were compared in a 3-month double-blind, multi-centre, randomized study. Efficacy was measured by an assessment of polyp size, nasal peak-flow index and the patient's assessment of nasal symptoms. The conclusions were that the size of polyps could be assessed in a reproducible way, and that budesonide delivered either as a water-based suspension or as an aerosol is effective in the treatment of patients with small and medium sized polyps.Keywords
This publication has 4 references indexed in Scilit:
- A double-blind comparison of intranasal budesonide with placebo for nasal polyposisJournal of Allergy and Clinical Immunology, 1990
- Peak flow nasal patency indices and self-assessment in septoplastyClinical Otolaryngology, 1990
- Budesonide nasal spray as prophylactic treatment after polypectomyThe Journal of Laryngology & Otology, 1988
- Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosolClinical and Experimental Allergy, 1975